The FDA has imposed a clinical hold on a Phase Ib trial assessing Pfizer’s mini-dystrophin gene therapy candidate PF-06939926 in Duchenne muscular dystrophy (DMD), after the company acknowledged the death of a young male participant in the open-label study.
The American Academy of Neurology offers ethical guidance on how to counsel patients and their families about the use of the controversial anti-amyloid aducanumab for Alzheimer s disease.
Jonathan Mink | Rochester Business Journal rbj.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from rbj.net Daily Mail and Mail on Sunday newspapers.
Combining the cannabidiol with various doses of tetrahydrocannabinol may reduce number of seizures in children and young adults with epilepsy, new research suggests.